Category: Featured

  • China’s Vaping Rules Force Retailer to Close

    China’s Vaping Rules Force Retailer to Close

    Image: Argus

    Chinese online retailer FastTech is closing in the wake of strict new vaping regulations, reports Vaping360.

    In a Dec. 5 post on its customer forum, the discounter blames restrictions introduced after the State Tobacco Monopoly Administration took control of China’s vaping business. The new measures have increased uncertainty, preventing the company from remaining competitive, according to the firm.

    China outlawed domestic online vape sales in 2019. The measure was followed by licensing and sales regulations along with the new tax scheme. Hong Kong’s ban on importing Chinese vape products for air shipping to export destinations—which is currently being reconsidered—may also have affected FastTech, which shipped many of its products through the city.

    FastTech sold Chinese-made vape products, including many semi-legal clones and copies of well-known products, to overseas customers at sometimes near-wholesale prices and shipped them inexpensively.

    According to Vaping360, there remain a number of FastTech competitors in China operating on a similar business model.

  • Smoking Prevalence Down in the Philippines

    Smoking Prevalence Down in the Philippines

    Photo: junpinzon

    The share of tobacco use among Filipinos aged 15 and above decreased to 19.5 percent of the population in 2021, reports GMA News Online, citing results of the 2021 Global Adult Tobacco Survey (GATS).

    Vito Roque Jr. of the Department of Health’s (DOH) Epidemiology Bureau attributed the decline to the adoption and implementation of tobacco prevention and control health policies and interventions. “The results also reflect the effectiveness of the enforced key policies on tobacco taxation, graphic health warnings, protection of bureaucracy against tobacco industry interference and smoke-free environments,” he added.

    Rising cigarette prices may have played a role as well. In 2009, a cigarette pack in the Philippines cost on average PHP30 ($0.54). By 2021, this figure had increased to PHP100 per box.

    Based on the 2021 GATS results, one in every five Filipino adults, or 15.1 million adults, currently use tobacco, among whom the percentage of males (34.7 percent) who currently use tobacco was eight times higher than females (4.2 percent).

    Meanwhile, at least 11.2 million adults currently smoke daily, or about 14.5 percent of the adult population. The percentage of male smokers who smoke daily (26.3 percent) is nearly nine times higher than the percentage of women smokers who smoke daily (3.6 percent).

    The average number of cigarettes smoked per day among daily cigarette smokers was 10.5 sticks, with men smoking a daily average of 10.8 sticks and women 6.7 sticks.

    The survey said that the overall prevalence of those who have ever used e-cigarettes among all adults was 5.7 percent while the current use of e-cigarettes was 2.1 percent.

  • COP10 Urged to Consider Harm Reduction

    COP10 Urged to Consider Harm Reduction

    Photo: lovelyday12

    The Coalition of Asia Pacific Tobacco Harm Reduction Advocates’ (CAPHRA) nine member organizations have written to Framework Convention for Tobacco Control (FCTC) delegation heads from around the world, urging them to review the evidence that supports a tobacco harm reduction (THR) approach ahead of COP10.

    With governments sending delegates to COP10 in November 2023, CAPHRA was keen to send leaders comprehensive reference material for their COP10 planning, submission writing and deliberations.

    COP10 will be held in Panama and is hosted by the World Health Organization’s FCTC.

    “We do this on behalf of the 4 million current users of safer nicotine products in the wider Asia-Pacific region. As you are aware, our region bears the brunt of the harm and death from combustible and unsafe oral tobacco globally,” said the letter.

    The CAPHRA representatives reminded the health leaders that the FCTC has a mandate to pursue harm reduction as a core tobacco control policy.

    “It has been known for decades that tar and carcinogens found in tobacco smoke cause the death and disease associated with smoking, not nicotine. Research has proven that nicotine, while usually mildly addictive in the same way as caffeine, is not a health issue,” they wrote.  

    The letter also called on delegates to deplore the FCTC’s policy to conduct COP10 sessions behind closed doors.

    “Delegates to COP10 should be representing the rights and aspirations of the citizens whose taxes are paying for their attendance, who expect them to speak on their behalf, acknowledge the science underpinning the harm reduction benefits of ENDS and maintain democratic principles,” they wrote.

    The CAPHRA representatives asked countries to take into account, when making their COP10 submissions, that consumers have the right to make choices that help them avoid adverse health outcomes. What’s more, people who smoke have the right to access less harmful nicotine products as alternatives to smoking.

    The evidence-based documentation was wrapped up in a recently released white paper, titled “The Subversion of Public Health: Consumer Perspectives,” which was presented by CAPHRA executive coordinator Nancy Loucas at the fifth Asia Harm Reduction Forum.

  • New Genes Connected to Tobacco Addiction

    New Genes Connected to Tobacco Addiction

    Image: Vlad Kochelaevskiy

    Over 2,300 genes are associated with alcohol and tobacco use, according to new Penn State research published in Nature.

    “We’ve now identified more than 1,900 additional genes that are associated with alcohol and tobacco use behaviors,” said Dajiang Liu, professor and vice chair for research in the Department of Public Health Sciences. “A fifth of the samples used in our analysis were from non-European ancestries, which increases the relevance of these findings to a diverse population.”

    About 400 genes were discovered in a previous research study.

    “It is promising to see that the same genes are associated with addictive behaviors across ancestries,” said Liu in a statement. “Having more robust and diverse data will help us develop predictive risk factor tools that can be applied to all populations.”

    Within two years to three years, according to Liu, using these genetic risk factors would be refined and become routine in care for individuals already identified as having increased risk for alcohol and tobacco use.

    “This project leveraged large amounts of data to identify common genetic risk factors across diverse populations,” said Kevin Black, interim dean of the College of Medicine. “Using these findings to develop screening tools for diseases of despair is the kind of innovation that will help our college lead the way in using health informatics to contribute to health preservation and disease treatment in our communities.”

  • Cancer Society Concerned About Nicotine Pouches

    Cancer Society Concerned About Nicotine Pouches

    Photo: Andrii

    The American Cancer Society is concerned about the growing popularity of nicotine pouches.

    Overall U.S. sales of nicotine pouches increased during 2019–2022, according to a new study published in the Journal of the American Medical Association (JAMA) Network Open. The data also showed sales of 8 mg nicotine concentration level (highest available) products rose more rapidly than those with different concentration levels.

    “Our findings are important as nicotine is a highly addictive substance. The growing popularity of nicotine pouches may increase the risk of children finding these products to be attractive and risk-averse health outcomes and addiction to nicotine,” said Nigar Nargis, senior scientific director of tobacco control research at the American Cancer Society and senior author of the study, in a statement. “Health campaigns warning of potential adverse health outcomes of nicotine pouches are needed.”

    Study authors analyzed data comprising weekly Nielsen IQ Retail Scanner point of purchase sales from August 2019 through March 2022 for 2,182 local trade areas in the contiguous 48 states and Washington, D.C. Sales trends of four nicotine pouch brands (Zyn, Rogue, On! and Velo) were analyzed.

    The results showed overall sales increased from 126.06 million units from August to December 2019 to 808.14 million units from January to March 2022. Zyn (58.8 percent) led the overall unit share followed by On! (24.6 percent), Velo (12.1 percent) and Rogue (4.8 percent) during the study period. Zyn sales peaked in September 2021 and increased more than other brands from October 2021 to March 2022; however, Rogue sales increased more rapidly than all other brands.

  • BAT Reports Continued Gains in Noncombustibles

    BAT Reports Continued Gains in Noncombustibles

    Photo: BAT

    BAT gained 3.2 million consumers within its noncombustible business during the first nine months of 2022, thanks in part to new product launches and geographic expansion, CEO Jack Bowles wrote in a trading update.

    The New Category business continues to drive strong volume, revenue and market share growth and has become a significant contributor to group performance, according to BAT.

    The global value share of Vuse vapor cigarettes reached 35.7 percent in key vapor markets by September 2022, up 2.2 percentage points over full-year 2021. In the U.S., the brand extended its leadership position by 6.8 percentage points, achieving a total value share of 39.3 percent.

    BAT’s Glo tobacco-heating product (THP) increased its category volume share by 1.6 percentage points in key THP markets to reach 19.5 percent by September 2022. In Europe, Glo achieved a 20.4 percent volume share in key THP markets, up 4 percentage points. In Japan, Hyper drove Glo’s total nicotine volume share up 50 base points versus 2021 to reach a share of 7.3 percent.

    BAT’s Velo modern oral brand reached a volume market share in Europe of 69.1 percent.

    Meanwhile, BAT reported a flat combustible cigarette value share, with gains in the United States, Asia-Pacific and the Middle East offset by declines in the company’s Americas, Sub-Saharan Africa and Europe regions. In the U.S., BAT begun new sales strategies in the second half to offset “early signs of accelerated downtrading,” according to Bowles.

    BAT reiterated its guidance for mid-single percentage growth in adjusted earnings per share at constant currency this year. Price increases and marketing campaigns should offset higher raw material prices, according to the company.

  • Court Blocks FDA Graphic Health Warnings

    Court Blocks FDA Graphic Health Warnings

    Image: FDA

    A federal judge has blocked the U.S. Food and Drug Administration from enforcing a rule requiring tobacco manufacturers to print graphic warning labels on their products, citing the companies’ First Amendment rights, reports Law360.

    The Family Smoking Prevention and Tobacco Control Act of 2009 instructs the FDA to create visual health warnings, but the D.C. Circuit in 2012 blocked the agency’s first attempt, saying that regulators had not convincingly demonstrated that the warnings would actually reduce smoking.

    In March 2020, the FDA released the final rule requiring new graphic warnings for cigarettes that feature some of the lesser known but still serious health risks of smoking, such as diabetes, on the top half of the front and back of cigarette packages and at least 20 percent of the area on the top of cigarette advertisements.

    R.J. Reynolds Tobacco Co., ITG Brands and Liggett Group filed a First Amendment challenge in April 2020. The rule was set to take effect in November 2023 after it was repeatedly pushed back by court.

    In a lengthy opinion issued Dec. 7, U.S. District Judge J. Campbell Barker of the U.S. District Court for the Eastern District of Texas vacated the FDA’s rule after finding that the required label statements and graphic images are not narrowly tailored to the agency’s interest in promoting public awareness of the health risks of smoking.

    “The government has not shown that compelling these large graphic warnings is necessary in light of other options,” the judge said, noting that the government could put more effort into public awareness campaigns.

    Public health campaigners were aghast. “Today’s decision by a federal judge to block implementation of graphic cigarette warnings ordered by the Food and Drug Administration is wrong on the law, inconsistent with decades of precedent and harms public health,” read a joint statement issued by the American Academy of Pediatrics, American Cancer Society, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids and Truth Initiative.

    “We urge the justice department to appeal this decision, and we are confident that the FDA’s warnings will ultimately be upheld by a higher court.”

    The health groups also noted that the U.S. had fallen behind other countries with its tobacco control policies. Prior to 2009, when Congress passed the Tobacco Control Act, only 18 countries required graphic warnings for tobacco products, they pointed out. Today, more than 120 countries require them.

  • Bristol Mayor Vetoes ‘Navy Cut’ Road

    Bristol Mayor Vetoes ‘Navy Cut’ Road

    Illustration: iconsgraph

    Bristol Mayor Marvin Rees vetoed naming a South Bristol road after a tobacco product following pushback from Action on Smoking and Health (ASH), reports Bristol Live.

    The road was set to be named Navy Cut Road after a brand produced by the Imperial Brands tobacco factory that formerly occupied that area. After ASH said that was “morally unacceptable,” however, Rees vetoed the name in favor of naming the road after Florence Mills Brown, the first female lord mayor.

    Councilor Richard Eddy criticized the move, saying that Mayor Rees is “imposing” his will on the citizens of the area.

    “Having served on Bristol City Council for 30 years, it does not escape me that, contrary to all previous practice, your team is not seeking the views of my local community and its elected councilors on a proposed street-naming within my neighborhood,” Eddy wrote in an email.

    “Whilst I’m sure former Lord Mayor Florence Brown was a creditworthy woman, why name a road here after a Labour politician who represented two wards miles away in North Bristol and has no discernible links to Bishopsworth?

    “This is not just a small disagreement over street naming in a southern city suburb, but it goes to the heart of the debate about whether Bristol should be ruled by one man with a ‘God complex’ or whether local communities and their duly elected councilors should determine their own destinies.”

  • Juul Settles More than 5,000 Lawsuits

    Juul Settles More than 5,000 Lawsuits

    Photo: steheap

    Juul Labs has settled more than 5,000 lawsuits covering more than 10,000 individual plaintiffs, reports The Wall Street Journal. The deal resolves much of the legal uncertainty that had driven the company close to bankruptcy.

    Juul announced on Dec. 6 that it has secured an investment to cover the cost of the settlement. The company has been in talks with two early investors to fund a bailout that would cover legal liabilities.

    According to Juul CEO K.C. Crosthwaite, the settlement addresses the vast majority of outstanding litigation facing the company, including two pending bellwether trials that were set to go to court early next year and four broad groups: personal injury plaintiffs, Juul consumers, government entities such as school districts and Native American tribes. Lawsuits brought by several attorneys general are pending. 

    A pioneer in the vaping business, Juul Labs has gone from dominating the U.S. e-cigarette market to fighting for its survival in a relatively short time.

    Following its initial success, the company quickly came under regulatory scrutiny over its marketing practices. Critics blame Juul Labs for contributing to an “epidemic” of underage vaping.

    Thousands of lawsuits have been filed against Juul over the past several years, alleging that the company marketed its e-cigarettes to children. Juul has said it never marketed to underage users.

    In September, Juul Labs agreed to pay nearly $440 million to settle a two-year investigation by 33 U.S. states into the marketing of its vaping products.

    Juul’s e-cigarettes were briefly banned in the U.S. in late June after the Food and Drug Administration concluded that the company had failed to show that the sale of its products would be appropriate for public health. But following an appeal, the health regulator put the ban on hold and agreed to an additional review of Juul’s marketing application.

    In October, Juul published the details of its marketing denial order appeal. In late September, Juul shareholder Altria Group exercised the option to be released from its noncompete deal with the e-cigarette maker.

  • Companies to Post ‘Corrective Statements’

    Companies to Post ‘Corrective Statements’

    Image: Wirestock | Adobe Stock

    Tobacco companies will have to start displaying signs with “corrective” statements about the health effects and addictive nature of cigarettes at U.S. points of sale in the second half of 2023, according to the Department of Justice (DOJ), reports Fox News. A court order requiring the statements will take effect July 1, 2023, after which tobacco companies will have three months to start posting the statements for 21 months in English and Spanish.

    The order “resolves the government’s long-running civil racketeering lawsuit against the largest United States cigarette companies,” according to the DOJ. The racketeering lawsuit was filed in 1999 and ended in 2005; however, the DOJ said the new court order is the last of several corrective remedies related to that case.

    Altria Group, Philip Morris USA, R.J. Reynolds Tobacco Co. and four cigarette brands owned by ITG Brands are subject to the order. An estimated 200,000 of 300,000 retail stores in the U.S. that sell cigarettes have agreements with the tobacco companies. The order requires the companies to amend their agreements, requiring corrective statements to be placed at the stores on color signs that are eye-catching. Messaging will include adverse health effects of smoking, the addictive nature of nicotine and adverse health effects of secondhand smoke, among others.

    “Justice Department attorneys have worked diligently for over 20 years to hold accountable the tobacco companies that defrauded consumers about the health risks of smoking,” said Associate Attorney General Vanita Gupta. “Today’s resolution implements the last remedy of this litigation to ensure that consumers know the true dangers of the smoking products they may consider purchasing.”

    “This is an important moment in the history of cancer control in the United States,” said William Klein, associate director of the National Cancer Institute’s behavioral research program. “Smoking causes about 30 percent of all cancer deaths in the United States, and therefore, the court-ordered corrective statements appearing at the point of cigarette sale will help support our mission to reduce the burden of cancer. We are grateful to our colleagues at the Department of Justice for having completed this significant work.”